Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
  August 23, 2012
 
In This Edition
News Roundup: Amgen Halts Phase III Oncology Trial
Articles: Phase I Oncology Trial Considerations
Blog Posts: Public-Private Partnerships Step Up
Marketplace: Marketplace

News Roundup
bullet Oracle's Translational Research Center to Support Cancer Research UK
bullet Novartis and UofP Collaborate on Cancer
bullet Amgen Halts Phase III Study for Pancreatic Cancer
bullet IRBs Establish Oncology-Focused Review Boards
bullet China and US Collaborate on Cancer Research

Sponsored
Optimizing Early Phase Oncology Clinical Trials
Explore key considerations and trial management issues in early phase oncology trials. Identify key infrastructure elements, explore and address challenges that emerge when working with oncology patients in early phase trials, and examine trends in trial design and cohort management. View Whitepaper


Articles
bullet Considerations for Successful Phase I Oncology Trials
bullet What Is Industry Learning From Terminated Oncology Trials?
bullet Recruitment Drivers for Oncology Trials
bullet Are Emerging Markets the Only Answer to Oncology Trial Recruitment?

Blogs Posts
bullet Quintiles 2012 New Health Report
bullet Public-Private Partnerships Step Up
bullet Last Chance to Take Study Optimization Survey

Marketplace

Sponsored
IMS Health DV
Live Webcast: Optimizing Site Performance Using An Evidence Based Site Selection Process.
www.appliedclinicaltrials online.com/selectionprocess

Sponsored
INC Research
September 25 Webcast: Best Practices for Biosimilar Development Programs.
www.appliedclinicaltrials online.com/bestpractices

Sponsored
Registrat-MAPI
September 19 Webcast: Assessing Drug Effectiveness in Observational Studies using PROs.
http://appliedclinicaltrials online.com/drugeffectiveness

 

Follow Us


Ask The Editor

Lisa Henderson
Editor in Chief
[email protected]


Webcasts & Events
bullet CBI's 7th Annual Effective Oncology Benefit Management—A Forum for Payers, Oct. 25-26
bullet Bio/Pharmaceutical Imaging Forum, Dec 11-12
bullet Clinical, Regulatory and Commercialization Strategies for Rare Diseases